Cardiology Research and Practice / 2011 / Article / Tab 1

Clinical Study

Multiple Coronary Artery Thrombosis in 5,10-Methylenetetrahydrofolate Reductase Gene Mutation

Table 1

Summary of thrombophilia screening laboratory findings.

TestsResults (normal range)

Prothrombin time10.80 seconds (8.9–11.7)
International normalized ratio (INR)0.96 (0.90–1.14)
Activated partial thromboplastin time25.7 (24.5–35.2)
Homocysteine (Hcy)>50 μmol/L (4.00–15.40)
Protein C activity (%)122% (72–160)
Protein S activity (%)152% (79–183)
Antithrombin III activity108.0% (82.0–112.0)
Factor V Leiden mutationNegative
Prothrombin gene mutationNegative
Phospholipid (cardiolipin) AB IgG1.8 U/mL GPL (0–10)
Phospholipid (cardiolipin) AB IgM0.0 U/mL MPL (0–10)
Lupus anticoagulantAbsent

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.